79
© 2010 Mayo Foundation for Medical Education and Research. All Rights Reserved. Loralie J Langman, PhD DABCC (CC, MD, TC), F-ABFT Director Clinical and Forensic Toxicology Laboratory, Mayo Clinic Professor, Mayo Clinic College of Medicine Rochester, MN September 30, 2016 Urine Drug Screening: The Essentials of Interpretation

Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

  • Upload
    others

  • View
    9

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Loralie J Langman PhD DABCC (CC MD TC) F-ABFT Director Clinical and Forensic Toxicology Laboratory Mayo Clinic

Professor Mayo Clinic College of Medicine Rochester MN

September 30 2016

Urine Drug Screening The Essentials of Interpretation

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

DISCLOSURE

Relevant Financial Relationship(s) None

Off Label Usage None

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

50 y old male

Prescribed bull Percocet 5325

You want to see if he is taking it hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Testing

What specimen to collect

Is the individual impairedunder the influence now

Was an individual using or exposed to a drug

BLOOD SERUM

URINE

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screening

How do we do what we do

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 2: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

DISCLOSURE

Relevant Financial Relationship(s) None

Off Label Usage None

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

50 y old male

Prescribed bull Percocet 5325

You want to see if he is taking it hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Testing

What specimen to collect

Is the individual impairedunder the influence now

Was an individual using or exposed to a drug

BLOOD SERUM

URINE

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screening

How do we do what we do

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 3: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

50 y old male

Prescribed bull Percocet 5325

You want to see if he is taking it hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Testing

What specimen to collect

Is the individual impairedunder the influence now

Was an individual using or exposed to a drug

BLOOD SERUM

URINE

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screening

How do we do what we do

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 4: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Testing

What specimen to collect

Is the individual impairedunder the influence now

Was an individual using or exposed to a drug

BLOOD SERUM

URINE

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screening

How do we do what we do

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 5: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screening

How do we do what we do

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 6: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screening

How do we do what we do

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 7: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screening

How do we do what we do

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 8: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Traditional Drug Screening

Classically Two Stages

bull Stage 1 ndash Screen

bull Stage 2 ndash ConfirmationDefinitive Testing

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 9: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How do Immunoassay Screens work

Usually immunoassay-based method

Detect compounds that ldquolook likerdquo the drug you are testing for

Purpose is to identify negative samples

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 10: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Designed to look for illicit opiate use HEROIN rarr morphine

More practically thought of as a morphine immunoassay

Therefore detection of other opiates (ex codeine

hydrocodone hydromorphone oxycodone oxymorphone hellip) depends on antibody specificity

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 11: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

morphine oxycodone OH OHO

NCH3

O OO

NCH3

CH3

OH

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 12: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate Screening Immunoassay

Assay 1

Oxycodone ~ 20 cross reactivity bull Need ~ 5X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 1500 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Assay 2 Oxycodone ~ 3 cross reactivity bull Need ~ 33X more oxycodone to

give a positive Opiate Screen result than morphine

bull ~ 9900 ngmL oxycodone to give a positive screening test when a 300 ngmL cut-off is used

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 13: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines Presumptive Positive 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates negative 300

oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 14: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Identify what is causing the positive result in the immunoassay screening assay

OR

What to order when you are looking for a specific drug

May or may not be quantitative

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 15: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Laboratory Medicine Practice Guideline Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Recommendation First-line definitive testing (qualitative or quantitative) is

recommended for detecting the use of relevant over-the-counter medications prescribed and non-prescribed drugs and illicit substances in pain management patients Definitive urine drug testing specifically identifies or quantifies a drug andor its metabolites

bull Strength of recommendation A bull Quality of evidence II

httpswwwaaccorgcommunitynational-academy-of-clinical-biochemistry

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 16: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 17: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 18: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Targeted Opioid Screen

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 19: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive Testing

Done in the Lab bull Gas Chromatography Mass Spectrometry

rsaquo (GCMS) bull Liquid Chromatography Mass Spectrometry

rsaquo (LCMS LCMS-MS TOF QTOF)

Pro bull Identify the drug(s)

Con

bull Looks for specific drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 20: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 21: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism

Phase 1 Reactions

Oxidation bull CYP450

Reduction

Phase 2 Reactions

Conjugation Reactions bull Glucuronidation bull Sulfate bull Glutathione bull Glucine bull Acetylation bull Methylation

Generally these reactions generate compounds that are more water soluble - aid in excretion

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 22: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism

Parent Drug MajorActive Metabolite (s) morphine codeine morphine heroin 6-mono-acetylmorphine morphine hydromorphone hydrocodone hydromorphone oxymorphone oxycodone oxymorphone

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73 Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 23: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Metabolism hellip and more

Parent Drug Minor metabolite

of parent drug

References

morphine hydromorphone lt25 Cone EJ et al J Anal Toxicol 2006 30(1) p 1-5

codeine hydrocodone lt11 Oyler JM et al J Anal Toxicol 2000 24(7) p 530-5

High doses for long period of time

Parent Drug Contaminant of parent drug

References

heroin codeine NOT metabolite

Very low levels compared to morphine

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 8th Edition Ed

2008 Chemical Toxicology Institute Foster City CA

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 24: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Acceptable Impurities in Commercial Drug Preparations Active Pharmaceutical Ingredient (API)

Process impurity ()

Allowable limit ()

Typical observed ()

hydrocodone codeine 015 000 ndash 010

hydromorphone morphine hydrocodone

015 010

000 ndash 0025 000 ndash 0025

morphine codeine 050 001 ndash 005

oxycodone hydrocodone 100 002 ndash 012

oxymorphone hydrocodone oxycodone

015 050

003 ndash 010 005 ndash 040

NOTE All contaminants when detected in greater amounts than the allowable limits stated above would be considered evidence of use These are NOT metabolites

Pesce A et al Interpretation of urine drug testing in pain patients Pain medicine 2012 13(7) p 868-85

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 25: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 26: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1

Opiate Confirmation (LC-MSMS)

Drug LOD

oxycodone 6600 ngmL 100 ngmL

oxymorphone 8152 ngmL 100 ngmL

morphine negative 100 ngmL

codeine negative 100 ngmL

hydrocodone 250 ngmL 38 100 ngmL

hydromorphone negative 100 ngmL

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 27: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 contrsquod

Patient is also prescribed Ritalin (methyl phenidate)

Urine Immunoassay Screen

Drug Result Cut-off (ngmL) amphetamines Presumptive Positive 500 barbiturates negative 200 benzodiazepines negative 200 cannabinoids negative 20 cocaine metabolite negative 150 opiates negative 300 oxycodone Presumptive Positive 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 28: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 1 cont

NH2

CH3 NH

O OH

amphetamine methylphenidate

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 9th Edition Ed 2011 Chemical Toxicology Institute Foster City CA Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th Ed 2011 McGraw-Hill

NHCH3

CH3

methamphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 29: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are Whaaaaaaaaaaaaaat

Screening methods try to pick up as much as possible but to

do that you sacrifice of the detection limit and the ability to identify exactly which drug it is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 30: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

copyGetty images

Drug Screens

One could say that

drug screening is like looking for a needle in a haystack hellip

when you donrsquot know what the needle looks like or if there is a needle at all

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 31: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

If you know what you are looking for order a test that looks for it specifically (Definitive Testing)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 32: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

50 y old female

Prescribed bull methadone 60 mgd

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 33: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 34: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

Opiate

The term is often incorrectly used to refer to all drugs with morphine-like pharmacological action

More properly classified under the broader term opioid

httpdictionaryreferencecombrowseOpiate httpenwikipediaorgwikiOpiatecite_note-0

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 35: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiate vs Opioid

An opioid is a chemical substance that has a morphine-like action in the body

Natural opiates - alkaloids contained in the resin of the opium poppy bull morphine codeine hellip

Semi-synthetic opiates - created from the natural opiates

bull hydromorphone hydrocodone oxycodone oxymorphone diacetylmorphine (Heroin) hellip

Fully synthetic opioids bull fentanyl meperidine (pethidine) methadone tramadol hellip

Endogenous opioid peptides - produced naturally in the body

bull endorphins enkephalins dynorphins and endomorphins

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 12th ed New York McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 36: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opiates

O OHO

NCH3

CH3codeine

OH OO

NCH3

hydromorphone OH OO

NCH3

OH

oxymorphone

O OO

NCH3

CH3

OH

oxycodone O OO

NCH3

CH3hydrocodone

OH OHO

NCH3

morphine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 37: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Opioids in the Opiate assay

Opioids bull No ldquochemicalrdquo similarity to opiates

morphine OH OHO

NCH3

methadone

N

CH3

CH3

CH3

O CH3

fentanyl

N

N

CH3

O

tramadol

OCH3

NCH3 CH3

OH

meperidine

N

O

O

CH3

CH3

tapentadol

NCH3OH

CH3

CH3 CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 38: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2

Urine Immunoassay Screen

Drug Result Cut-off (ngmL)

amphetamines negative 500

barbiturates negative 200

benzodiazepines negative 200

cannabinoids negative 20

cocaine metabolite negative 150

opiates Presumptive Positive 300

oxycodone negative 100

methadone negative 300

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 39: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Case 2 cont hellip

Urine

Methadone Confirmation (GC-MS) Methadone 175 ngmL Screening assay cut off 300 ngmL

EDDP (methadone metabolite)

12062 ngmL

Confirmatory methods typically have limits of quantitation lower than the screening method

amp Why to order it when you know you are looking for it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 40: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methadone

Patients who are taking methadone for therapeutic purposes usually excrete both parent methadone and EDDP in their urine

BUT hellip

Methadone levels in urine are widely variable depending on factors such as dose timing of collection metabolism and urine pH (can even be undetectable)

EDDP levels in contrast are relatively unaffected by the influence of pH and are therefore preferable for assessing compliance with therapy

bull measure levels of both methadone and EDDP

Principles of Forensic Toxicology 2nd ed Washington DC AACC Press 2003

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 41: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another complicated class of drugs hellip

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 42: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepines

General Structure

N

N

Cl

OCH3

diazepam

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 43: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine Drug Phase I Phase II Lorazepam glucuronidation clonazepam 7-amino-clonzaepam glucuronidation Flunitrazepam 7-amino-flunitrazepam glucuronidation

Triazolam Hydroxy-traizolam glucuronidation Alprazolam Hydroxy-alprazolam glucuronidation Midazolam Hydroxy-midazolam glucuronidation Flurazepam Hydrox-fluazepam glucuronidation

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 44: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Drug Metabolism Benzodiazepine

Chlordiazepoxide Demoxepam

Diazepam

glucuronidation

Nordiazepam

Temazepam Oxazepam

EXCRETION

glucuronidation

oxidation CYP450

oxidation CYP450

oxidation CYP450

Baselt RC Disposition of Toxic Drugs and Chemicals in Man 7th Edition Ed 2005 Chemical Toxicology Institute Foster City CA Boerner U The metabolism of morphine and heroin in man Drug Metab Rev 1975 4(1) p 39-73

Goodman amp Gilmans The Pharmacological Basis of Therapeutics 10th Ed 2001 McGraw-Hill

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 45: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Benzodiazepine Immunoassay

The cross-reactivity of the different manufactures immunoassays to the over 30 prescribed benzodiazepines are even more variable than the opiates one

bull Clonazepam cross-reactivity is almost universally poor

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 46: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Tip

If you are looking for a specific drug hellip

Tell us

bull The more information the lab has the better

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 47: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 48: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Definitive methods hellip

Identify the drug(s) indicated with certainty hellip

So can those results be false positives too

But you just said they were definitive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 49: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

False Positives

Clinical False Positive Methodological False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 50: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 51: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamines

Amphetamine and methamphetamine have limited legitimate pharmacological uses including narcolepsy obesity and attention-deficit hyperactivity disorders

There are also prescription drugs that are metabolised to amphetamine or methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Logan BK Forensic Sci Rev 2002 14(p133-151

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 52: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Clinical False Positive

Drug uses Metabolites Adderall amphetamine ADHD Dexedrin d-amphetamine Narcolepsy

ADHD Desoxyn methamphetamine ADHD

amphetamine

Deprenyl selegiline Parkinsonrsquos Disease

methamphetamine amphetamine

Geowdin famprofazone Analgesic antipyretic

methamphetamine amphetamine

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 53: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

A thorough review of medical history to determine what medications the patient is prescribed

Canrsquot rule out they DIDNrsquoT use amphetamine or

methamphetamine

But does explain a positive test

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 54: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Point to Remember

An awareness of the patients completerecent medication history is critical to prevent the individual from being wrongly accused of using illicit drugs

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 55: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methodological False Positive

A drug is confirmedidentified when the drug is absent

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 56: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Amphetamine Type Stimulants cont

Amphetamine-type stimulants are often chiral compounds

Generally bullS(+) enantiomers stimulate the central nervous system bullR(-) enantiomers act peripherally

Illicit amphetamine-type stimulants are mixtures of S(-) and

R(-) enantiomers

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC

CH3

NH2

H H

NH2

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 57: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

CNS effects of S(+) methamphetamine [d-methamphetamine] are ~ 10X greater

Vasoconstrictive effects of R(minus) methamphetamine [l-methamphetamine] are greater

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

NHCH3

CH3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 58: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Methamphetamine

Because of the minimal CNS activity and therefore low abuse potential R(minus) methamphetamine [l-methamphetamine] was included in some nonprescription nasal decongestants because of its vasoconstrictive properties

They have largely been replaced with other decongestant medications

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9

Hornbeck CL et al J Anal Toxicol 1993 17(1) p 23-5 Poklis A et al Ther Drug Monit 1995 17(1) p 89-94

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 59: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Some prescription drugs either have chiral amphetamine or methamphetamine as the active ingredient or are metabolised to chiral methamphetamine or amphetamine Drug Drugs detected

Dexedrin d-amphetamine S(+) amphetamine Deprenyl selegiline R(-) methamphetamine

R(-) amphetamine Vyvanse lisdexamfetamine

( L-lysine-dextroamphetamine) S(+) amphetamine

Logan BK Forensic Sci Rev 2002 14 p 133-151 Romberg RW et al J Forensic Sci 1995 40(6) p 1100-2

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 60: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

How to approach the casehellip

Routine confirmatory testing does not distinguish between the enantiomers

Chiral discrimination of methamphetamine isomers may be

necessary to distinguish

bull use of nonprescription nasal inhalants bull chiral prescription medications

from illicit use of methamphetamine

Principles of Forensic Toxicology 2nd Ed 2003 p 245-264 AACC Press Washington DC Cody JT J Chromatogr 1992 580(1-2) p 77-95

Fitzgerald RL et al J Anal Toxicol 1988 12(5) p 255-9 Hughes RO et al J Anal Toxicol 1991 15(5) p 256-9

Rasmussen LB et al J Chromatogr B Analyt Technol Biomed Life Sci 2006 842(2) p 136-41

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 61: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Urine Concentrations Levels in urine vary widely depending on factors such as

bull dose bull hydration status bull timing of collection bull metabolism bull hellip

CANNOT relate a urine concentration back to a dose

But within a given patient the pattern is may be ldquostablerdquo

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 62: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 63: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 64: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
Page 65: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 66: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 67: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 68: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drug ngmL creatinine gdL

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 69: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 70: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
Page 71: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 72: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 73: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 74: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Another way to look at urine results

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

sample

drugcreatinine

What this tells you is that something changed bull Disease bull Concomitant medications bull Altered compliance bull

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 75: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Chart3

EDDP
creat
ratio
sample

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
3000 50 60
4500 90 50
2000 363636363636 55
3489 87225 40
4321 960222222222 45
6500 1083333333333 60
3583 7166 50
2679 487090909091 55
2965 456153846154 65
4328 961777777778 45
3579 5965 60
500 142857142857 35
4084 907555555556 45
3925 603846153846 65
400 75 53333333333
327 60 545
4598 707384615385 65
4328 961777777778 45
3579 5965 60
3579 7158 50
4084 742545454545 55
Page 76: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet1

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
sample EDDP creat ratio
1 3000 500 600
2 4500 900 500
3 2000 364 550
4 3489 872 400
5 4321 960 450
6 6500 1083 600
7 3583 717 500
8 2679 487 550
9 2965 456 650
10 4328 962 450
11 3579 597 600
12 500 143 350
13 4084 908 450
14 3925 604 650
15 400 750 53
16 327 600 55
17 4598 707 650
18 4328 962 450
19 3579 597 600
20 3579 716 500
21 4084 743 550
Page 77: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet1

EDDP
creat
ratio
sample

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 78: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet2

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 79: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Sheet3

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 80: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

The Key to understanding and interpreting drugs screens is

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 81: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Know what the lab can detect and let them know what you need

Drug screen interpretation requires two-way communication

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 82: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

A positive result bull They were exposed to the drug(s) identified bull Cant tell the dose or when it was taken

A negative result

bull Doesnrsquot exclude the possibility they were exposed to drug(s)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 83: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

The lab can tell you what active drug(s) was taken NOT the formulation

The lab CANNOT test for diversion bull We can help identify if a patient has not taken the drug bull but we canrsquot tell you what else the patient did with it

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 84: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Is the right test ordered

bull Be specific in what you order ndash you will only get what you ask for

bull Reminder

rsaquo Opiate vs opioids

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 85: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Relating a urine drug concentration to dose is difficult because

bull kidneyrsquos concentrating ability bull hydration of patient bull timing of collection (in relation to dose) bull hellip

Intuitively higher levels ~ recent use andor large dose

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 86: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Points to Take Home

Are any additional tests required

bull Do you require creatinine or specific gravity bull Do you require additional tests to screen for adulterants

rsaquo pH oxidants

bull Do you require Chain of Custody

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 87: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

langmanloraliemayoedu

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 88: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Focus on urine drug testing (UDT)

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 89: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Stimulants

Substance Period of Detection Amphetamine 1-3 days Methamphetamine 1-3 days Amphetamine variants (MDA MDMA)

1-3 days

Cocaine (benzyolecgonine) 1-4 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 90: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Opioids and Morphine Derivatives

Substance Period of Detection Morphine 1-3 days Codeine 1-3 days Oxycodone 1-3 days Methadone and metabolite (EDDP)

1 day - 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 91: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Alcohol 6-10 hours Barbiturates

Short acting 1 day Intermediate acting 2-3 days

Long acting 7-10 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 92: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Depressants

Substance Period of Detection Benzodiazepines

Short acting 1 day Intermediate acting 2-4 days

Long acting 1 week

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 93: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection LSD 8 hours Mescaline 2-3 days Phencyclidine 2-8 days Psilocybin 8 hours Amphetamine variants DOB DOM MDA MDMA

1-3 days

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
Page 94: Urine Drug Screening: The Essentials of Interpretation - sylabus UDS.pdfFirst-line definitive testing (qualitative or quantitative) is recommended for detecting the use of relevant

Department of Laboratory Medicine and Pathology copy 2010 Mayo Foundation for Medical Education and Research All Rights Reserved

Interpretation Detection Times Hallucinogens

Substance Period of Detection Marijuana

Single use 1-3 days Several times a week 2 weeks

daily 3-6 weeks

wwwnidanihgov

These are approximate detection times for the drug or metabolites in urine The actual detection time depends on individual metabolism and the dose of the drug

  • Slide Number 1
  • DISCLOSURE
  • Case 1
  • Drug Testing
  • Slide Number 5
  • Case 1
  • Drug Screening
  • Traditional Drug Screening
  • How do Immunoassay Screens work
  • Opiate Screening Immunoassay
  • Slide Number 11
  • Opiate Screening Immunoassay
  • Case 1
  • Definitive Testing
  • Laboratory Medicine Practice GuidelineUsing Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Targeted OpioidScreen
  • Definitive Testing
  • Case 1
  • Drug Metabolism
  • Metabolism
  • Metabolism hellip and more
  • Acceptable Impurities in Commercial Drug Preparations
  • Case 1
  • Case 1
  • Case 1 contrsquod
  • Case 1 cont
  • Drug Screens are good a finding things you didnrsquot know you were looking for hellip Not good at finding things you are
  • Drug Screens
  • Slide Number 31
  • Case 2
  • Case 2
  • Opiate vs Opioid
  • Opiate vs Opioid
  • Opiates
  • Opioids in the Opiate assay
  • Case 2
  • Case 2 cont hellip
  • Methadone
  • Another complicated class of drugs hellip
  • Benzodiazepines
  • Drug Metabolism Benzodiazepine
  • Drug Metabolism Benzodiazepine
  • Benzodiazepine Immunoassay
  • Tip
  • Definitive methods hellip
  • Definitive methods hellip
  • False Positives
  • Clinical False Positive
  • Amphetamines
  • Clinical False Positive
  • How to approach the casehellip
  • Point to Remember
  • Methodological False Positive
  • Amphetamine Type Stimulants cont
  • Methamphetamine
  • Methamphetamine
  • Slide Number 60
  • How to approach the casehellip
  • Interpretation Urine Concentrations
  • Another way to look at urine results
  • Another way to look at urine results
  • Another way to look at urine results
  • Slide Number 66
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Points to Take Home
  • Slide Number 73
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times
  • Interpretation Detection Times